Essity


A well-balanced health and hygiene proposition

08/01/19 -"Recommendation and upside We are initiating coverage of Essity (market cap: SEK152bn/€15bn and free float: 91%) with an ‘Add’ recommendation and a target price of SEK229 per share (5.5% upside). Our ..."

Pages
47
Language
English
Published on
08/01/19
You may also be interested by these reports :
19/03/19
We have taken the CARE+ related additional costs into account. Additionally, we have started to factor in the guidance regarding working capital and ...

11/03/19
A net cash pile at €4bn (and rising, coming from €1.6bn 10 years ago) to match a market cap at €22bn, a flat dividend at €0.7 since … 2009 and a ...

11/03/19
We have applied a 20% premium to our peer valuation to gauge better L’Oréal’s stronger growth profile (organic growth of 7.1% in FY18 vs. an average ...

27/02/19
Preceding the full set of 2018 figures (preliminary had already been released), Beiersdorf announced CARE+ a kind of wake-up programme. It needs ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO